FDA Recall Terminated

ARCHITECT/AEROSET Activated Aspartate Aminotransferase The Activated Asparate Aminotransferase (Activated AST) assay is used for the quantitation of asparate aminotransferse in human serum or plasma

Recall: Z-1447-2012 · Initiated June 30, 2008

Recall

Recall Number
Z-1447-2012
Event Number
50072
Firm
Abbott Laboratories Inc.
FEI Number
2018433
Product Code
CIT
Status
Terminated
Root Cause
Nonconforming Material/Component
Initiated
June 30, 2008
Posted
April 23, 2012
Terminated
April 23, 2012
Address
820 Mission St, South Pasadena, CA, 91030-3142

Description

ARCHITECT/AEROSET Activated Aspartate Aminotransferase The Activated Asparate Aminotransferase (Activated AST) assay is used for the quantitation of asparate aminotransferse in human serum or plasma

Reason

This letter is to inform you that some samples may generate A-AST results of less than (<) 5 U/L or results within the reference range when actual concentration exceeds the non-Flex linearity of 1985 U/L. In other cases the following errors may be generated. -ARCHITECT cSystems: Error Code 1053 (Unable to calculate result, rate reaction linearity failure) -AEROSET: RL% Error Code Revised P

Action

Abbott Laboratories sent a Product Correction letter dated August 5, 2008, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to do the following: Update your assay parameters for A-AST 1. Follow the steps in the appropriate attachment: - Use Attachment A for ARCHITECT cSystems - Use Attachment B for AEROSET. 2. All A-AST results of less than (<) 5 U/L should be evaluated by comparing to other clinically relevant assays Retain a copy of this letter for your laboratory records. For questions regarding this recall call 626-440-0705.

Distribution

Worldwide Distribution including Germany

Quantity

1,646